Shire Inks $56.5M FCA Settlement Over Adderall Marketing
Shire PLC agreed Wednesday to shell out $56.5 million to resolve allegations that it violated the False Claims Act through improper marketing and promotion of five drugs intended to treat both...To view the full article, register now.
Already a subscriber? Click here to view full article